Cancer-Targeting Compound 1 Catalog No.:M24216-C Smiles: C[C@@H]1O[C@@H](O[C@@H]2[C@H](OC3=CC(O)=CC(O)=C3C2=O)C2C=CC(O)=CC=2)[C@H](O)[C@H](O)[C@H]1O

Smiles: C[C@@H]1O[C@@H](O[C@@H]2[C@H](OC3=CC(O)=CC(O)=C3C2=O)C2C=CC(O)=CC=2)[C@H](O)[C@H](O)[C@H]1O

InChiKey: NKOJNOBJGYTLLZ-KRWDZBQOSA-N

3)14-22-29(19-12-7-15(30)13-21(19)34-27(29)38)23(18-5-4-6-20(31)24(18)32)25(35-22)26(37)33-16-8-10-17(36)11-9-16/h4-7

This drug may represent an additional therapeutic paradigm for the treatment of XFG

and 108 nM for rNPY Y1

Cancer-Targeting Compound 1 Catalog No.:M24216-C Smiles: C[C@@H]1O[C@@H](O[C@@H]2[C@H](OC3=CC(O)=CC(O)=C3C2=O)C2C=CC(O)=CC=2)[C@H](O)[C@H](O)[C@H]1OCancer Targeting Compound 1 is used in the research of hormone related cancer, extracted from patent WO 2008021331 A2. Product information CAS Number: 1007581 62 5 Molecular Weight: 299. 35 Formula: C15H13N3O2S Chemical Name: 4 [2 (4,4 dimethyl 2 oxo 1,3 oxazolidin 3 yl) 1,3 thiazol 4 yl]benzonitrile Smiles: CC1(C)COC(=O)N1C1=NC(=CS1)C1C=CC(=CC=1)C#N InChiKey: OLHKCEIOFAUDPT UHFFFAOYSA N InChi: InChI=1S C15H13N3O2S c1 15(2)9 20 14(19)18(15)13 17 12(8